Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2004 1
2008 1
2010 3
2011 2
2012 3
2013 3
2014 5
2015 3
2016 4
2017 6
2018 8
2019 6
2020 8
2021 8
2022 16
2023 8
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

76 results

Results by year

Filters applied: . Clear all
Page 1
A Phase 3 Trial of Luspatercept in Patients with Transfusion-Dependent β-Thalassemia.
Cappellini MD, Viprakasit V, Taher AT, Georgiev P, Kuo KHM, Coates T, Voskaridou E, Liew HK, Pazgal-Kobrowski I, Forni GL, Perrotta S, Khelif A, Lal A, Kattamis A, Vlachaki E, Origa R, Aydinok Y, Bejaoui M, Ho PJ, Chew LP, Bee PC, Lim SM, Lu MY, Tantiworawit A, Ganeva P, Gercheva L, Shah F, Neufeld EJ, Thompson A, Laadem A, Shetty JK, Zou J, Zhang J, Miteva D, Zinger T, Linde PG, Sherman ML, Hermine O, Porter J, Piga A; BELIEVE Investigators. Cappellini MD, et al. N Engl J Med. 2020 Mar 26;382(13):1219-1231. doi: 10.1056/NEJMoa1910182. N Engl J Med. 2020. PMID: 32212518 Clinical Trial.
Luspatercept for the treatment of anaemia in non-transfusion-dependent β-thalassaemia (BEYOND): a phase 2, randomised, double-blind, multicentre, placebo-controlled trial.
Taher AT, Cappellini MD, Kattamis A, Voskaridou E, Perrotta S, Piga AG, Filosa A, Porter JB, Coates TD, Forni GL, Thompson AA, Tartaglione I, Musallam KM, Backstrom JT, Esposito O, Giuseppi AC, Kuo WL, Miteva D, Lord-Bessen J, Yucel A, Zinger T, Shetty JK, Viprakasit V; BEYOND Investigators. Taher AT, et al. Lancet Haematol. 2022 Oct;9(10):e733-e744. doi: 10.1016/S2352-3026(22)00208-3. Epub 2022 Aug 22. Lancet Haematol. 2022. PMID: 36007538 Clinical Trial.
Management of the Sickle Cell Trait: An Opinion by Expert Panel Members.
Pinto VM, De Franceschi L, Gianesin B, Gigante A, Graziadei G, Lombardini L, Palazzi G, Quota A, Russo R, Sainati L, Venturelli D, Forni GL, Origa R. Pinto VM, et al. Among authors: graziadei g. J Clin Med. 2023 May 12;12(10):3441. doi: 10.3390/jcm12103441. J Clin Med. 2023. PMID: 37240547 Free PMC article. Review.
Microcytosis in Erythropoietic Protoporphyria.
Graziadei G, Duca L, Granata F, De Luca G, De Giovanni A, Brancaleoni V, Nava I, Di Pierro E. Graziadei G, et al. Front Physiol. 2022 Mar 3;13:841050. doi: 10.3389/fphys.2022.841050. eCollection 2022. Front Physiol. 2022. PMID: 35309058 Free PMC article.
RNA polymerase II pausing temporally coordinates cell cycle progression and erythroid differentiation.
Martell DJ, Merens HE, Caulier A, Fiorini C, Ulirsch JC, Ietswaart R, Choquet K, Graziadei G, Brancaleoni V, Cappellini MD, Scott C, Roberts N, Proven M, Roy NBA, Babbs C, Higgs DR, Sankaran VG, Churchman LS. Martell DJ, et al. Among authors: graziadei g. Dev Cell. 2023 Oct 23;58(20):2112-2127.e4. doi: 10.1016/j.devcel.2023.07.018. Epub 2023 Aug 15. Dev Cell. 2023. PMID: 37586368
RNA Polymerase II pausing temporally coordinates cell cycle progression and erythroid differentiation.
Martell DJ, Merens HE, Fiorini C, Caulier A, Ulirsch JC, Ietswaart R, Choquet K, Graziadei G, Brancaleoni V, Cappellini MD, Scott C, Roberts N, Proven M, Roy NB, Babbs C, Higgs DR, Sankaran VG, Churchman LS. Martell DJ, et al. Among authors: graziadei g. medRxiv [Preprint]. 2023 Mar 7:2023.03.03.23286760. doi: 10.1101/2023.03.03.23286760. medRxiv. 2023. PMID: 36945604 Free PMC article. Updated. Preprint.
Psychological Aspect and Quality of Life in Porphyrias: A Review.
Francesca G, Nicolli A, Colaiocco A, Di Pierro E, Graziadei G. Francesca G, et al. Among authors: graziadei g. Diagnostics (Basel). 2022 May 10;12(5):1193. doi: 10.3390/diagnostics12051193. Diagnostics (Basel). 2022. PMID: 35626348 Free PMC article. Review.
Recognized and Emerging Features of Erythropoietic and X-Linked Protoporphyria.
Di Pierro E, Granata F, De Canio M, Rossi M, Ricci A, Marcacci M, De Luca G, Sarno L, Barbieri L, Ventura P, Graziadei G. Di Pierro E, et al. Among authors: graziadei g. Diagnostics (Basel). 2022 Jan 8;12(1):151. doi: 10.3390/diagnostics12010151. Diagnostics (Basel). 2022. PMID: 35054318 Free PMC article. Review.
Selecting β-thalassemia Patients for Gene Therapy: A Decision-making Algorithm.
Baronciani D, Casale M, De Franceschi L, Graziadei G, Longo F, Origa R, Rigano P, Pinto V, Marchetti M, Gigante A, Forni GL. Baronciani D, et al. Among authors: graziadei g. Hemasphere. 2021 Apr 29;5(5):e555. doi: 10.1097/HS9.0000000000000555. eCollection 2021 May. Hemasphere. 2021. PMID: 33969274 Free PMC article. Review.
Porphyrias at a glance: diagnosis and treatment.
Cappellini MD, Brancaleoni V, Graziadei G, Tavazzi D, Di Pierro E. Cappellini MD, et al. Among authors: graziadei g. Intern Emerg Med. 2010 Oct;5 Suppl 1:S73-80. doi: 10.1007/s11739-010-0449-7. Intern Emerg Med. 2010. PMID: 20865478 Review.
76 results